This seminar focuses on the case study of human papillomavirus (HPV) vaccination in the UK. The HPV vaccine is now offered to girls and boys aged 12–13, as well as to men who have sex with men. The vaccine helps prevent cervical, head and neck, and anogenital cancers caused by HPV infection, as well as genital warts.